Skip to main content
. 2017 Sep 18;12:6909–6921. doi: 10.2147/IJN.S144184

Table 1.

Characterization of nanoparticles

Nanoparticles Size (nm) Zeta potential (mV) PDI Drug loading (%) EE (%)
Sali-NP 123.2±14.1 −25.6±4.2 0.12±0.06 8.8±2.7 59.2±9.3
Sali-NP-HER2 135.6±17.6 −28.3±5.8 0.15±0.03 8.0±3.9 55.4±8.5

Note: Data are expressed as mean ± SD (n=3).

Abbreviations: EE, encapsulation efficacy; PDI, polydispersity index; Sali-NP, salinomycin-loaded polymer–lipid nanoparticles; Sali-NP-HER2, salinomycin-loaded polymer–lipid hybrid anti-HER2 nanoparticles.